Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis.
Saved in:
| Title: | Risk of relapse after discontinuation of tocilizumab therapy in giant cell arteritis. |
|---|---|
| Authors: | Adler, Sabine1,2, Reichenbach, Stephan2, Gloor, Andrea2, Yerly, Daniel3, Cullmann, Jennifer L.4, Villiger, Peter M.2 Peter.Villiger@Insel.ch |
| Source: | Rheumatology. Sep2019, Vol. 58 Issue 9, p1639-1643. 5p. 1 Chart, 1 Graph. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
